|
ZNF707 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.620400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.968400E-01 |
| Normal-vs-Stage2 |
2.270600E-01 |
| Normal-vs-Stage3 |
1.514420E-01 |
| Normal-vs-Stage4 |
8.085200E-01 |
| Stage1-vs-Stage2 |
6.259200E-01 |
| Stage1-vs-Stage3 |
4.816200E-01 |
| Stage1-vs-Stage4 |
4.596400E-01 |
| Stage2-vs-Stage3 |
9.698600E-01 |
| Stage2-vs-Stage4 |
3.816800E-01 |
| Stage3-vs-Stage4 |
2.637000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.950200E-02 |
| Normal-vs-AfricanAmerican |
1.698320E-03 |
| Normal-vs-Asian |
2.241800E-03 |
| Caucasian-vs-AfricanAmerican |
1.13989999994679E-06 |
| Caucasian-vs-Asian |
8.16190000000327E-05 |
| AfricanAmerican-vs-Asian |
3.446800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.729800E-02 |
| Normal-vs-Female |
8.103800E-01 |
| Male-vs-Female |
3.056900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.341200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.715200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.717850E-01 |
| Normal-vs-Age(81-100Yrs) |
2.005400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.100800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.134200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.249000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.291000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.225400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.119200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.697800E-03 |
| Normal-vs-Grade 2 |
3.245800E-01 |
| Normal-vs-Grade 3 |
8.114100E-02 |
| Normal-vs-Grade 4 |
4.185600E-01 |
| Grade 1-vs-Grade 2 |
1.283560E-03 |
| Grade 1-vs-Grade 3 |
1.606140E-04 |
| Grade 1-vs-Grade 4 |
5.456200E-03 |
| Grade 2-vs-Grade 3 |
3.367200E-01 |
| Grade 2-vs-Grade 4 |
9.852000E-01 |
| Grade 3-vs-Grade 4 |
5.071800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.612100E-04 |
| Normal-vs-ccB subtype |
2.605600E-01 |
| ccA subtype-vs-ccB subtype |
1.434110E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.008200E-02 |
| Normal-vs-N1 |
4.868200E-01 |
| N0-vs-N1 |
7.679000E-01 |
|
|
